Oscar Health, Inc. (NYSE:OSCR) COO Steven Wolin Sells 19,580 Shares

Oscar Health, Inc. (NYSE:OSCR) COO Steven Wolin sold 19,580 shares of the firm’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the sale, the chief operating officer now owns 102,598 shares of the company’s stock, valued at $1,854,971.84. This trade represents a 16.03 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Oscar Health Price Performance

OSCR stock traded down $0.44 during mid-day trading on Tuesday, hitting $17.99. 6,121,611 shares of the stock were exchanged, compared to its average volume of 3,427,490. The stock has a market capitalization of $4.45 billion, a price-to-earnings ratio of -307.12 and a beta of 1.64. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a 12 month low of $7.50 and a 12 month high of $23.79. The business has a fifty day moving average price of $17.33 and a 200 day moving average price of $17.99.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm’s quarterly revenue was up 68.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.29) EPS. On average, sell-side analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current year.

Analyst Ratings Changes

OSCR has been the subject of several research reports. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and cut their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Finally, UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. One analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Oscar Health has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Institutional Investors Weigh In On Oscar Health

A number of large investors have recently made changes to their positions in OSCR. State Street Corp raised its stake in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock worth $108,867,000 after buying an additional 291,335 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Oscar Health by 11.7% during the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after purchasing an additional 455,205 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after acquiring an additional 934,600 shares during the last quarter. Assenagon Asset Management S.A. increased its position in shares of Oscar Health by 32.9% during the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after acquiring an additional 507,009 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Oscar Health by 20.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock worth $33,940,000 after purchasing an additional 270,223 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.